genOway S.A.
ALGEN.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 10% | 17.6% | 21.6% | – |
| Gross Profit | -€0 | €0 | -€0 | -€0 |
| % Margin | -8.5% | 93.8% | -7.7% | -26.7% |
| EBITDA | €0 | €0 | €0 | -€0 |
| % Margin | 17.7% | 31.7% | 3.1% | -13.4% |
| Net Income | €0 | €0 | €0 | -€0 |
| % Margin | 8.3% | 7.8% | 4.6% | -2.3% |
| EPS Diluted | 0.2 | 0.17 | 0.088 | -0.037 |
| % Growth | 17.6% | 92.7% | 341% | – |
| Operating Cash Flow | €0 | €0 | €0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | €0 | €0 | -€0 |